Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced the approval of equity grants to two new employees as approved by the Compensation Committee of Codexis’s Board of Directors. The newly hired employees received equity awards consisting of an aggregate of (i) options to purchase 14,881 shares of Codexis’ common stock and (ii) restricted stock units (RSUs) for 8,928 shares of Codexis common stock as inducement awards under the company’s 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4).
Related news for (CDXS)
- Today’s Top Performers: MoBot’s Market Review 08/14/25 10:00 AM
- Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
- Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
- Codexis Announces Byron Dorgan to Retire from Board of Directors
- 24/7 Market News Snapshot 09 April, 2025 – Codexis, Inc. (NASDAQ:CDXS)